Skip to main content
Navigate Up
Sign In

Welcome to the Department of Neurology

Neurology Banner Image
 

Movement Disorders

Clinical Research



If you think you may qualify for one of these studies, please contact Professional Research Assistant (PRA) below for more information.

Search for: (view all)

COMIRB # Title (Please click on the title to see approved advertisement) Principal Investigator PRA
16-0017 Diagnostic and Rating Tools for Blepharospasm Berman, Brian D., MD, MS Nicola Haakonsen
303-724-4644
Eligibility and Information
12-0289 Functional Connectivity of the Basal Ganglia in Primary Focal Dystonia: A Pilot Project Berman, Brian D., MD, MS Nicola Haakonsen
303-724-4644
Eligibility and Information
10-1311 Functional Connectivity of the Motor Network in Two Major Subtypes of Parkinson Disease Berman, Brian D., MD, MS Nicola Haakonsen
303-724-4644
Eligibility and Information
11-0647 Natural History and Biospecimen Repository for Dystonia Berman, Brian D., MD, MS Erika Shelton
303-724-5865
Eligibility and Information
15-0170 Validation of a performance-based assessment of functional ability related to cognition in Parkinson’s disease Holden, Samantha, MD Nicola Haakonsen
303-724-4644
Please contact PRA for eligibility and information
11-0952 Defining Cognitive and Motor Phenotypes of Parkinson’s Disease (PD) with Magnetoencephalography Kluger, Benzi M., MD, MS Nicola Haakonsen
303-724-4644
Please contact PRA for eligibility and information
15-0814 Does outpatient palliative care improve patient-centered outcomes in Parkinson's disease? Kluger, Benzi M., MD, MS Nicola Haakonsen
303-724-4644
Eligibility and Information
15-0929 A randomized, double blind, placebo-controlled crossover study of tolerability and efficacy of Cannabidiol (CBD) on tremor in Parkinson’s disease Leehey, Maureen A., MD Nicola Haakonsen
303-724-4644
Eligibility and Information
15-1274 A Phase 3, Open-Label Study of the Safety, Efficacy, and Tolerability of Apomorphine Administered by Continuous Subcutaneous Infusion in Advanced Parkinson’s Disease Patients with Unsatisfactory Control on Available Therapy Leehey, Maureen A., MD Nicola Haakonsen
303-724-4644
Eligibility and Information
15-2328 A randomized, double-blind, placebo-controlled trial of urate-elevating inosine treatment to slow clinical decline in early Parkinson’s disease Leehey, Maureen A., MD Nicola Haakonsen
303-724-4644
Eligibility and Information
13-2509 Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers Leehey, Maureen A., MD Nicola Haakonsen
303-724-4644
Please contact PRA for eligibility and information
16-0684 An Open-Label, Phase 3 Study Examining the Long-Term Safety, Tolerability and Efficacy of APL-130277 in Levodopa Responsive Patients with Parkinson’s Disease Complicated by Motor Fluctuations (“OFF” Episodes) Lauren Seeberger, MD Nicola Haakonsen
303-724-4644
Eligibility and Information
15-2350 A Phase III, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy and Safety of Gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) to Immediate Release CD/LD in Fluctuating Parkinson’s Disease Patients Lauren Seeberger, MD Nicola Haakonsen
303-724-4644
Eligibility and Information
15-2058 An Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Irritable Subjects with Huntington's Disease (HD) Lauren Seeberger, MD Nicola Haakonsen
303-724-4644
Eligibility and Information